Ad
related to: ketamine use in elderly patients
Search results
Results from the WOW.Com Content Network
t. e. Ketamine-assisted psychotherapy (KAP) is the use of prescribed doses of ketamine as an adjunct to psychotherapy sessions. KAP shows significant potential in treating mental disorders such as treatment-resistant depression (TRD), anxiety, obsessive–compulsive disorders (OCD), post-traumatic stress disorders (PTSD), and other conditions. [1]
But the scientific evidence showing that ketamine can be helpful in patients with treatment-resistant depression and suicidal ideation is strong and goes back at least 20 years.
Ketamine is used as a recreational drug for its hallucinogenic and dissociative effects. [24] When used recreationally, it is found both in crystalline powder and liquid form, and is often referred to by users as "Special K" or simply "K". The long-term effects of repeated use are largely unknown, and are an area of active investigation.
Ketamine's rise in the dance culture was most rapid in Hong Kong by the end of the 1990s. [32] Ketamine use as a recreational drug has been implicated in deaths globally, with more than 90 deaths in England and Wales in the years of 2005–2013. [37] They include accidental poisonings, drownings, traffic accidents, and suicides. [37]
“Ketamine can trigger psychosis in patients who are at increased risk,” Ross says. “People with a strong family history of psychosis (such as schizophrenia) or serious mood disorders (such ...
The main rationale behind the use of ketamine-assisted psychotherapy is its recognition as an effective antidepressant. [ 1 ] [ 8 ] [ 22 ] [ 23 ] With depressive symptomology being a major co-morbid problem with trauma-related disorders, treating depression can help treat the trauma and provide opportunities for the therapist to address other ...
Ketamine can provide help and hope to patients who have not found relief with any other treatments." ... Musk talked about his ketamine use in an interview with former CNN anchor Don Lemon in ...
Ketamine has been tested as a rapid-acting antidepressant [22] for treatment-resistant depression in bipolar disorder, and major depressive disorder. [23] Spravato, a nasal spray form of esketamine, was approved by the FDA in 2019 for use in treatment-resistant depression when combined with an oral antidepressant. [24] [25]
Ad
related to: ketamine use in elderly patients